https://www.iop-target.org/ 2025-10-12T01:48:04+00:00 1.00 https://www.iop-target.org/default.aspx 2025-10-12T01:48:04+00:00 0.80 https://www.iop-target.org/about.aspx 2025-10-12T01:48:04+00:00 0.80 https://www.iop-target.org/newsmulti_Class.aspx 2025-10-12T01:48:04+00:00 0.80 https://www.iop-target.org/activity_Class.aspx 2025-10-12T01:48:04+00:00 0.80 https://www.iop-target.org/glaucoma_Class.aspx 2025-10-12T01:48:04+00:00 0.80 https://www.iop-target.org/story_Class.aspx 2025-10-12T01:48:04+00:00 0.80 https://www.iop-target.org/Chapter_Class.aspx 2025-10-12T01:48:04+00:00 0.80 https://www.iop-target.org/link.aspx 2025-10-12T01:48:04+00:00 0.80 https://www.iop-target.org/contact.aspx 2025-10-12T01:48:04+00:00 0.80 https://www.iop-target.org/newsmulti_detail.aspx?CatID=b63edc6d-6e09-4b74-9dff-153bab9622d9&ID=c37b11f8-f00b-49a9-aacd-5784e33185ad 2025-10-12T01:48:04+00:00 0.80 https://www.iop-target.org/newsmulti_detail.aspx?CatID=b63edc6d-6e09-4b74-9dff-153bab9622d9&ID=0b8209ff-fbb8-4c83-a01b-08e48ea87312 2025-10-12T01:48:04+00:00 0.80 https://www.iop-target.org/newsmulti_detail.aspx?CatID=8ac0e538-1a1d-453d-a509-26222b8760c6&ID=9a68b5ff-eb8a-4be2-8a97-a4e9719c2eea 2025-10-12T01:48:04+00:00 0.80 https://www.iop-target.org/about.aspx?ID=c3d3d60f-80b4-4990-bd18-68bc83e3738b 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/about.aspx?ID=99a1354b-4f9d-4d86-a03a-a4930c1f930d 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/about.aspx?ID=78ad62d2-e32a-499f-b728-f5073dc1f380 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/about.aspx?ID=13a3dab0-4bf4-410e-af2c-f0e3f16b84d1 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/about.aspx?ID=14818153-ed13-4b8b-9db7-5f5f0dd4ad9f 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/about.aspx?ID=264c94d9-5e58-4665-8bc8-103bfa794dc6 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/about.aspx?ID=526d904b-f339-4e37-8fa0-de5a8107d750 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/NewsMulti.aspx?CatID=b63edc6d-6e09-4b74-9dff-153bab9622d9 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/NewsMulti.aspx?CatID=429a645f-27b0-4a58-9210-369ee3bbe31f 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/NewsMulti.aspx?CatID=9019e881-d32b-4128-8792-a299c64457d8 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/NewsMulti.aspx?CatID=8ac0e538-1a1d-453d-a509-26222b8760c6 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/Activity.aspx?CatID=f3c634ba-ecd6-4aee-9eab-92df515ac4c4 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/Activity.aspx?CatID=9b3d3c90-e38a-4a61-b969-64da69839293 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/Activity.aspx?CatID=66c88cc2-b323-4e71-92b1-d0e2dd6aeb69 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/Activity.aspx?CatID=18eee6fc-c5bb-484e-b538-fa0b79c98ce8 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/glaucoma.aspx?CatID=5c6ad557-65b8-4a76-a07c-826f81aa5d17 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/glaucoma.aspx?CatID=3966e8ea-191f-4330-b791-9fcedc09c710 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/glaucoma.aspx?CatID=0eb24ca3-b70b-4fca-a13b-1331a6df2c61 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/glaucoma.aspx?CatID=3da8842b-9436-483f-b54b-0a302afc0bf2 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/Story.aspx?CatID=afb2c351-5079-47f8-88a6-2677c7eb4b18 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/Story.aspx?CatID=af70e74f-cff1-4786-a7b0-12202c33ef36 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/Story.aspx?CatID=cbb1ad1d-18af-4dcb-bf97-4e07d42ef22c 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/Story.aspx?CatID=4f110229-c116-4e88-bbda-c5d09204c5be 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/Chapter.aspx?CatID=363cd15d-b461-449f-a483-b1ce908a7d3d 2025-10-12T01:48:04+00:00 0.64 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=c37b11f8-f00b-49a9-aacd-5784e33185ad 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=0b8209ff-fbb8-4c83-a01b-08e48ea87312 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=ed95f2a8-665e-4e91-864e-804199beda79 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=faa34a35-5815-48ac-8175-204bea4454f5 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=7beb0def-11e2-400f-9da8-589201585520 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=e0eeae90-4a36-4fcb-8600-6e705ca426dd 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=e14e0d69-a189-4e77-b4a8-303d10ce5fe7 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=26468677-e21e-4eea-aa69-7f8f44345799 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=13965f62-5d2f-423d-9b91-9daec95eda03 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=2a319761-f016-467c-8666-c850cf3c6c2c 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=28376b67-e7ea-4dc9-947a-202909a4324d 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=f91dc6da-8c54-40ff-9874-f3966950d5fa 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=9e8bdd95-0aca-41f2-90ae-becdb36b86ca 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=74fa4fe3-e4f7-405d-b48b-b85fc78d6d28 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=1b5be99d-a68e-475b-87ae-f414d9d44516 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=6ab89dc0-5190-4eb9-a0b9-e5816e9ea09e 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=aef52853-de58-452d-a6d1-ca6b8697e17f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=a849b9ad-0bbb-432f-8860-4a80bbf7fc69 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=540252d3-4d8f-4b8f-b0a7-aec6788821fe 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=703c2fff-8038-4e2a-bf2a-84ff852ca80a 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=868fc0e0-e88f-43d9-b8f2-7834e7761880 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=266fd34f-4d97-434c-b583-f4c6e99fc8b7 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=dafd1f23-620d-4804-be64-97376391a95b 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=b55bcb1c-030d-463a-aa05-94530c2794eb 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=f3e36888-2e95-48d1-ba0e-8754caeef9c7 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=24d6d0c6-5015-4f02-a0fa-3ab313ba54fd 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=eff2eb1f-765f-4c06-af82-c80c92272a9a 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=4c47699d-f86c-44a4-857c-34f38c555e56 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=e2f2f2bc-fa08-4ccf-a19d-4d0fd000b755 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=0f668240-93e6-4542-878b-27fc837b1365 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=61e0e3a8-0db6-455e-b3c0-0ec09996b66b 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=088dcd23-18c5-4341-a409-7a7a90ea6986 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=13729a16-fb3c-47a8-8b46-e700c6666c33 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=132b33e4-8f9b-4a11-b80a-79eace8ad19b 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=ce7d535e-2807-4752-8180-762a481e4d39 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=4a0b19cd-3768-4f95-aa64-c575b8b31497 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=f937f150-aa00-44cd-a641-ac177689ca03 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=68a314f2-fbac-4df3-9701-5f806a7a2420 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=a5e3e2d3-db3e-49ae-a359-841c0afed507 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=a0985313-8b32-4099-bd9b-690e3e169275 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=6d7f8aa1-b127-476a-953e-38cdc2ee6567 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=37769b47-ae02-40e2-a4a2-6afd75c538cd 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=2e2cd07f-1ecc-4686-b077-4b31148e36f3 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=f8723ac3-f848-46b7-90c5-c30bcff09ada 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=5629ddb4-2d04-4873-97d3-d75b0cf8a28a 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=34f652b3-58d6-41a3-ae43-e320006b38a0 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=1c83ea4c-03f4-4e17-bb2f-5acadf6fff61 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=8753a7f7-c519-4daa-b171-ba0a6671c102 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=1cb61073-f285-4d3f-b636-4601ad3e0f5e 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=8f0e2eaf-1378-418a-8ce8-5bf97abddbad 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=18e92588-edbf-4f9f-ae60-9e974fb1bd39 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=dc0b4ef2-163b-46e9-ad37-492ee7a89fc2 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=ef325ec0-624f-4d60-b31a-6ba23a1c1125 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=ec28a42b-6e55-428d-a079-6b2b9f38dbaf 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=3cfd0cc2-4330-4356-b1b6-e48053500b07 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=5dcd80bd-1784-4048-964a-1f24398b9532 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=e45b08e6-d7e8-4cd8-ba4b-61fbed17e40e 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=3458a10f-353c-44e2-b443-29873f632c9d 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=9b7a7b55-22a4-4f10-a538-73c322ca375f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=51c8f8cd-edad-4f83-9e59-f19e5f310a9b 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=32e863fe-b9f7-409a-9a58-c0e453ac7f1f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=9a68b5ff-eb8a-4be2-8a97-a4e9719c2eea 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=f1f3312c-68f3-45f0-8830-b21e949c2a80 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=768b828d-1d98-4835-842e-b053ba0f3756 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/NewsMulti_Detail.aspx?ID=a958c91b-435d-441a-86dd-3a70f28d7ce0 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=b0aa8d0a-1820-4512-96f7-6b4eabaacce6 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=60dec9a4-6afb-4947-ace5-cc074ac32704 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=bdef7a71-ebfc-44b1-b5a7-bed201c044b1 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=a103fc09-7444-44a6-9366-b03631bb8144 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=500c95e7-51a4-490f-823e-74fc35f7ddc9 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=6071dd04-a083-4456-bc65-a131577e4cc7 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=1609e82e-9af9-4ce5-8461-2d1a961e0e3a 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=357b6710-de5c-47a6-9e8d-33443d26f377 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=d452a062-6554-4584-9803-b22fbfa95634 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=adb175c7-df82-4772-bde4-9a61a14e707f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=3a688c42-a11b-4cc8-8466-695c4120547a 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=78e2abb6-ccbd-4376-b271-83c0d053de08 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=0a70ebcd-02a3-4e43-bcaf-f5052248af46 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=9f4726d9-c1a8-4da2-933a-c264f0c0ab1d 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=ef55ad9f-5194-415f-8539-ed51f51a6f67 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=a466a2d1-9612-425f-abaa-f7b8c3dc4e85 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=1e7e87c5-9517-44d3-8c0e-38e2e089cb7f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=312eb1d8-f1ee-4e43-bede-a7dd94e4d34e 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=9e03565b-2366-4bb7-8d5b-897474ed84f5 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=9b83363d-ae27-4f96-b9d1-789c4462c045 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=dfae2424-d895-48de-82b1-623a70f6c94f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=c6729c84-ba7f-435e-990d-d2acbf14bab8 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=1fa12dcc-0477-40ae-bf88-8d40b6da457e 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=b3d60ba0-1f7d-4135-8711-af7741c72904 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=8f4b5396-134a-4642-82b4-7e695383299f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=9146d734-c8cc-4a39-8995-b0fcb63fc4d3 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=b29c3900-54ce-4571-a17d-7e8005742fdf 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=4160afdb-ad7d-47b0-b966-5978c20deb68 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=089cb095-bd42-4bfb-887c-5c23aff1ee15 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=10e60f5c-c135-4fbf-aa7b-e17729a0f540 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=e04da3f1-be25-46d7-a675-e1c2d382fce0 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=630355d6-990f-40ba-b1b3-5726e4e7dff2 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=f1720e0e-f4fb-4cfd-998c-17d81005fbfe 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=c027dbdc-727f-417a-bffd-b3009b49cdbc 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=948acc82-9f6f-40ea-b6c1-54ed1692dffd 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=b1366cc6-d549-48d4-83e4-b319073b1ffc 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=e20561cf-ea22-432b-918c-c60b3e8bcabc 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=22b7a083-b17d-42f8-8451-4dc50898b796 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=7787630d-1859-47ae-accb-08bd75a75cd7 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=4b93a1c2-dbdd-4380-95c2-ddb4ba984218 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=ddaf46b0-6048-43b9-9ac7-acfc1af48a9c 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=462b35a2-bc74-47dd-89b0-c0b0fc24bbca 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=e64d1edb-8391-4885-8b47-2eeeca230e99 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=50da6fd5-6006-4482-9d80-595d9cc61a68 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=d9b92a44-0d4a-4810-9837-92b5c2c2b4f4 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=3a261708-0e71-4f60-85db-26468ef3af31 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=25be9ce4-18c4-431c-889f-2a1132c2b2cd 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=86feaf08-e901-45ab-888b-e4213e364013 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=03c054ce-3a99-473e-a3b1-07b7e544867d 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=729c576c-1cb0-408c-a40e-b6382639e321 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=6414cb52-8e7c-4c36-a73d-26f0e5677b64 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=42fa40aa-b099-44e9-bfbc-5fb070c3975a 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=ec1a6b49-48a1-4e55-ae0c-7a5dec7d59ce 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=db60bece-81f4-481d-ad33-1025a3161ed0 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=23d30785-8892-4db3-b037-9e9451946f54 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=7f6bb46a-4035-4cd3-a7db-0af44d935a3a 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=f69afe09-0325-4eda-a8e1-4db7ddcf8207 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=70320f6e-92f3-4680-9d2d-00b0ff984ef4 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=951d7981-46ae-47a4-a06f-c73934362e84 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=8cbfe02b-86ea-4c28-b87b-476de9bd0492 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=4c062318-19fa-417a-94e6-7a36bb091355 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=9e8118f4-dd65-463b-a7c4-7f5fd0c756c3 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=8ba087b5-8960-4cc5-a59d-af2f063ab431 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/glaucoma_Detail.aspx?ID=034d8ce6-8adb-402c-982f-1d5fecce5e2b 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=e1bc5be0-6c2f-4a52-b8a7-b75612dd3351 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=8c06dafd-c8b1-406a-bfd8-f017bcdb6772 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=7cb6c56a-6811-4123-a1c5-19dc506562de 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=0fde0e8e-7106-476d-8194-74b78c07b252 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=79fa7a88-7938-4adc-a41c-fc22f7a2d867 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=d4b35ab2-4969-40fc-8696-bfe7afc4039a 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=6580ded9-36c0-4900-8bcc-d36996e4af11 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=7bc8feef-ea79-446c-b748-3853e284801d 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=d31b7936-6d5a-4218-872d-03f1c0683e2e 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=6371ae94-fe9f-4219-861f-bc60858f1d29 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=4fc079c5-3c9d-477a-a8a8-68b41e0324d9 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=d0cc2fe4-1b90-4657-bbc6-5d39f01f914e 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=10ce0726-d6f4-4a9e-a3f4-f89366f64bd0 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=9b4f7a46-5082-4a09-a2b0-ee440c40dd0a 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=00c5fbb0-ff57-44de-be69-ba39d5062e74 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=f2e69006-dcb8-4d4e-8e1c-764a140804d8 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=e1ded847-2e2e-48d1-b3bb-8ac49e35fed7 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=51243d4d-249e-4d88-b316-32aad5a03d0e 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=c999da8f-64cc-4421-b34f-36cd4e400dda 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=41c6b722-9e52-4fd6-95fe-1173fc8f2371 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=cd7bef52-8311-4e6a-a767-2f4210542e1b 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=79c3681d-f5bd-49c7-8bd4-572090a28950 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=2ddb3d8e-69a3-495b-ab0c-1136edb7bdc8 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=6e540101-de50-4146-8b19-ae28402c740f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=12b9e298-ccee-4349-a6b1-5ef7b26e9c51 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=76e3ea3c-763f-424d-9eb4-492fd56c2a7e 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=d8c2d1fe-e0c1-4bf9-aa10-b46a9ea54eec 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=a38e5023-ca1c-4fe3-8dc6-8c50dc3f6a55 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=7a66c0f6-3067-4c11-8a76-048f4b9574ab 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=ce6d56b9-32d7-44c4-a413-aac902c36cb1 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=d68b4d23-3458-4001-a4ed-e4b4586eac25 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=a8b4e802-52ef-425c-8231-4983c2b658fc 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=ce5a70b3-a8af-44a7-ac22-40d65397abb7 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=ce0a80f6-a29f-4659-9113-d77792e92d0f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=2b8b1467-e797-4ed1-b9f2-e5764e15c650 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=87bfd5d1-2401-465a-a2e5-71d8cd553d66 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=488aa327-b2f8-4410-85ca-e177e85f2029 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=a4ddae12-a4bb-41bb-9067-def44aded2e3 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=39513fd7-6ca4-4ecb-ad9a-d6a5570b6a8a 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=0de0fd82-bb1c-4d65-a12b-8630fcecadfd 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=40aaacd8-7dfb-4235-ae1a-295989b3557b 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=890cbbcc-5df3-481b-aa7b-cf9e461095db 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=36a20bfd-49ef-45c3-866d-a76bf1521e81 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=457b9702-6c3a-4ed5-87ab-b87620a03c5c 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=271daeb3-2ab0-4921-8d6a-09813cb71626 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=771dce19-20e7-46f9-81ed-3182420ce7f4 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=64f313ec-f547-469b-98c6-ca4e2b0e7fff 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=bcfc1f30-462c-4560-8574-eea094e6c85b 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=a3649f15-8113-4674-8e98-b439d13e1b40 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=52b065cd-5437-4b59-9258-a8e614ff93ea 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=f54d14ac-adef-4dd1-80d0-25b2f84e770c 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=f8f1ce21-c7b2-4f14-b062-9e325a5d57de 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=b28e9deb-cad0-4de8-b43f-70ea4a5be24f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=f5a86fd5-1736-47d7-b291-c47660f9ebd7 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=e26dc2fd-c019-41ed-b96f-2c5f964a4e85 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=e1060d3c-732a-409d-839f-ce47a8e4fc38 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=e55c8557-73c7-4839-8cd9-591f1727c9ee 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=7fd04c15-07d6-4d1e-9f9b-b7f87fdbd81f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=4a28e143-9a8b-478b-9dfe-0cb82a4a68bb 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=4660cacf-7bba-482f-8d1c-41cd18346f57 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=e592fe12-cebf-4e7c-9e5f-a76bb4f5576d 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=2a5006bb-57ce-46d5-bca2-0bd983f9cd5b 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=927efdad-1bcb-4023-96ab-40f434929c7d 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=1c7bf8fc-a000-4ea2-8661-64ddb5e5f1bb 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=c519a924-d1ef-41cc-9c37-003362f75105 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=63f7aba1-270a-49b4-806e-9654256a2f0c 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=7420412d-4ecd-4674-9c49-2cb92250c8e2 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=9b7622e8-f5df-409f-a228-295b34e024d1 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=e8f86c63-e0e2-4bd3-9eee-d4915106ef87 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=f1c1b2e1-4dee-4bcf-92c7-9e65bd9a54ca 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=75be7c3a-c30b-4a9b-887b-0faf7b1cadf3 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=7ca5b2d5-bf05-4707-8319-be4ac0172a3f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=78bffbbe-bacc-4fda-bad1-8b7fe301be87 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=84013763-e204-463a-b3a3-2f6213d05ffc 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=fed468ab-41db-4a92-8847-0b2914d892d4 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=478b6ac6-9d2e-4d36-a501-196934c28258 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=a47ae559-d1fc-4b18-8907-896bfaa31b52 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=8505ebe9-f112-4b06-9adc-1297db04dbc1 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=c02a564f-e781-4c59-b3a9-9654ac09a74f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=ea4c702e-b5de-4d87-bb03-0ecf3738dd50 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=8d94dd78-1395-4360-8f9b-66466ac2f389 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=86b4eb42-ace4-4b66-aa39-949a672348d1 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=e8bb3f0c-3cae-4282-bea1-4ce4879443c4 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=145d9966-f4c0-45d0-adbf-59699105b56e 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=4befaf2f-3cdf-41ab-b033-9f0a077a3959 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=0f2d00cd-f390-4398-b302-8153112862c7 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=ecaecde0-52c5-4f66-9cc2-9ce4cebf99e3 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=480c382d-895f-4316-b2a0-68441a9e0618 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=2f8a2d55-f29f-4d10-9a31-5b66d50ae9ac 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=e14fc438-9f16-4e24-8ec7-786e4c560f7a 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=f1c772a1-6018-4457-ace9-600e200480c0 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=5361eac3-5070-4a5a-aa28-9908a7f95968 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=b3726d6f-716f-4ea5-ad15-c80596ba0337 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=e611ecdf-5300-4332-b4f3-85374ad23603 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=7ec94743-58a7-48ba-9037-e7a7b74fcb47 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=0d1e108e-65ba-432e-8cf5-d7c134cdb28f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=24932494-ac87-4c9e-a93c-08939e608e14 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=b1c76a39-0dd1-46e2-b404-7afb956ea0c7 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=83c48887-e992-400b-8e55-9e54f320652d 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=aa74f3d2-a898-4dc4-b8f3-dc0b8a111180 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=b41c1bfd-6fd4-4af8-b8f4-44ca8bd3d957 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=e673e3d8-3cf0-4f29-8621-2cbb8f16fa9b 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=69b65bea-17b2-4317-9834-7d5ada61693b 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=4a813f57-d67d-4e10-a069-e2d94bf4276f 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=ed179f84-6ddd-400f-bce7-bc30be9b062d 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=e835ea9a-67d5-4c5f-80b2-7b491693a1aa 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=2e462538-f25a-4937-8b19-5f0d5fdbdc77 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=3c70d141-6fd7-4150-bad5-125254058302 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Story_Detail.aspx?ID=c238cb47-b52f-4124-b7a3-d10d1c028e01 2025-10-12T01:48:04+00:00 0.51 https://www.iop-target.org/Chapter_Detail.aspx?ID=ba260f68-88c4-4b95-b2d9-c0a447e2fe3c 2025-10-12T01:48:04+00:00 0.51